Current Value
$1.131 Year Return
Current Value
$1.131 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CME | -18.43% | $96.05B | +23.35% | 3.94% |
CBOE | -14.56% | $22.97B | +19.12% | 1.11% |
PSQH | -11.93% | $116.30M | -44.12% | 0.00% |
HIHO | -11.61% | $8.28M | -7.84% | 6.38% |
MO | -10.51% | $98.21B | +29.23% | 6.90% |
KR | -10.17% | $46.83B | +13.50% | 1.93% |
PM | -10.12% | $237.07B | +65.37% | 4.37% |
MCK | -9.43% | $83.51B | +24.74% | 0.41% |
EZPW | -9.04% | $762.55M | +29.60% | 0.00% |
FATBB | -8.76% | $53.73M | -26.29% | 13.59% |
BTCT | -8.66% | $23.17M | +40.12% | 0.00% |
COR | -8.49% | $51.94B | +10.53% | 0.79% |
KO | -8.14% | $300.00B | +15.28% | 2.83% |
PGR | -7.74% | $160.98B | +33.59% | 1.79% |
BTI | -7.32% | $90.20B | +36.22% | 7.27% |
T | -7.27% | $192.30B | +56.12% | 4.14% |
KSPI | -6.34% | $18.21B | -20.19% | 3.83% |
ED | -6.22% | $38.30B | +22.37% | 3.09% |
TCTM | -6.14% | $3.22M | -84.87% | 0.00% |
STG | -5.75% | $29.37M | -42.04% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
IMNM | 39.41% | $733.28M | -64.13% | 0.00% |
GPRO | 39.24% | $122.95M | -66.48% | 0.00% |
KLIC | 38.03% | $1.92B | -27.32% | 2.87% |
NTLA | 37.88% | $900.60M | -68.54% | 0.00% |
RXRX | 37.76% | $2.60B | -39.15% | 0.00% |
SLAB | 37.69% | $4.05B | -7.60% | 0.00% |
CRSP | 37.38% | $3.53B | -44.74% | 0.00% |
CRBU | 37.33% | $93.00M | -80.95% | 0.00% |
ALEC | 36.82% | $128.81M | -79.13% | 0.00% |
ARCT | 36.67% | $348.22M | -61.24% | 0.00% |
ACLX | 36.28% | $3.92B | -0.90% | 0.00% |
KN | 36.27% | $1.41B | +3.47% | 0.00% |
LFUS | 36.15% | $5.22B | -8.66% | 1.29% |
ALLO | 36.07% | $354.14M | -62.79% | 0.00% |
OLED | 36.01% | $7.19B | -7.96% | 1.10% |
HCAT | 35.95% | $304.01M | -46.61% | 0.00% |
LSCC | 35.74% | $8.34B | -23.43% | 0.00% |
VYGR | 35.66% | $214.20M | -58.72% | 0.00% |
COHU | 35.07% | $788.93M | -46.02% | 0.00% |
DIOD | 35.04% | $2.12B | -33.96% | 0.00% |
Finnhub
Immunic Therapeutics Developing Selective Oral Therapies in Immunology NASDAQ: IMUX | March 2025 ...
Yahoo
Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced participation in the following scientific and investor conferences in March:
Yahoo
Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced the presentation of data on its lead asset, nuclear receptor-related 1 (Nurr1) activator, vidofludimus calcium (IMU-838), in two poster presentations at the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2025, taking place from February 27 to March 1, in West Pal
Finnhub
Immunic Therapeutics Developing Selective Oral Therapies in Immunology NASDAQ: IMUX | February 2025 ...
Yahoo
Key Insights Significant control over Immunic by retail investors implies that the general public has more power to...
Yahoo
Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced that IMU-856, an orally available and systemically acting small molecule modulator that targets SIRT6 (Sirtuin 6), demonstrated a dose-dependent increase of endogenous glucagon-like peptide-1 (GLP-1) levels in a post hoc analysis of patients from its phase 1b clinical trial in celiac disease. IMU-85
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
DKL | -0.02% | $2.34B | +6.86% | 10.05% |
CABO | 0.03% | $1.43B | -42.49% | 4.66% |
TEVA | 0.04% | $18.61B | +18.11% | 0.00% |
CIG.C | 0.05% | $2.51B | +28.31% | 0.00% |
MASI | 0.11% | $9.14B | +27.38% | 0.00% |
AGO | -0.13% | $4.35B | -5.38% | 1.48% |
BVN | -0.17% | $3.94B | -9.23% | 0.00% |
BROS | -0.18% | $7.61B | +83.86% | 0.00% |
SAFT | -0.20% | $1.14B | -4.61% | 4.66% |
ASPS | 0.20% | $21.91M | -67.29% | 0.00% |
REYN | 0.22% | $4.97B | -15.75% | 3.87% |
ACGL | 0.23% | $34.70B | +7.20% | 0.00% |
AU | -0.27% | $18.38B | +72.50% | 2.53% |
EXEL | -0.29% | $10.41B | +55.43% | 0.00% |
BNED | 0.30% | $329.64M | -83.66% | 0.00% |
BF.B | 0.32% | $16.51B | -32.38% | 2.56% |
PRGS | -0.32% | $2.35B | +2.51% | 0.65% |
LMT | 0.35% | $109.86B | +5.32% | 2.76% |
PEP | -0.35% | $201.82B | -14.67% | 3.69% |
STNG | -0.36% | $2.11B | -42.26% | 3.82% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -28.64% | $392.24M | 1.43% |
VIXY | -24.75% | $195.31M | 0.85% |
TAIL | -23.46% | $83.83M | 0.59% |
XHLF | -13.86% | $1.06B | 0.03% |
IBTF | -12.16% | $2.24B | 0.07% |
CTA | -10.73% | $927.03M | 0.76% |
IVOL | -10.12% | $459.41M | 1.02% |
DBE | -10.08% | $54.72M | 0.77% |
DBO | -9.47% | $190.57M | 0.77% |
UGA | -9.40% | $85.26M | 0.97% |
COMT | -8.67% | $671.56M | 0.48% |
BNO | -8.64% | $90.64M | 1% |
USO | -8.64% | $891.33M | 0.6% |
XONE | -8.60% | $621.86M | 0.03% |
USL | -8.54% | $45.36M | 0.85% |
GSG | -8.45% | $1.03B | 0.75% |
USDU | -8.42% | $214.47M | 0.5% |
OILK | -7.87% | $64.75M | 0.69% |
USCI | -7.80% | $228.07M | 1.07% |
BILS | -7.30% | $3.66B | 0.1356% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
SGOV | 0.01% | $38.60B | 0.09% |
DFIP | 0.02% | $865.56M | 0.11% |
VNLA | 0.02% | $2.39B | 0.23% |
GLD | -0.05% | $88.60B | 0.4% |
SCHO | -0.06% | $10.55B | 0.03% |
AAAU | -0.06% | $1.25B | 0.18% |
FTSM | 0.15% | $6.34B | 0.45% |
IEI | -0.15% | $15.59B | 0.15% |
IAU | -0.23% | $41.25B | 0.25% |
BSV | -0.24% | $34.47B | 0.03% |
OUNZ | -0.25% | $1.48B | 0.25% |
AGGH | 0.32% | $288.93M | 0.29% |
IYK | -0.32% | $1.43B | 0.4% |
SMMU | 0.41% | $681.00M | 0.35% |
SUB | 0.44% | $8.84B | 0.07% |
SHV | 0.45% | $19.68B | 0.15% |
BAR | -0.48% | $1.01B | 0.1749% |
SGOL | -0.48% | $4.65B | 0.17% |
FLMI | 0.54% | $601.72M | 0.3% |
IBMO | 0.59% | $505.91M | 0.18% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 46.30% | $5.66B | 0.35% |
IBB | 46.20% | $6.06B | 0.45% |
GNOM | 45.70% | $57.10M | 0.5% |
ARKG | 44.94% | $1.07B | 0.75% |
CPRJ | 44.72% | $48.98M | 0.69% |
RSPA | 44.45% | $280.76M | 0% |
BBH | 42.80% | $400.47M | 0.35% |
QQA | 42.50% | $167.69M | 0% |
PBE | 41.40% | $240.72M | 0.58% |
CPSJ | 41.06% | $33.01M | 0.69% |
PINK | 40.42% | $145.31M | 0.5% |
IWC | 39.48% | $845.76M | 0.6% |
FBT | 39.31% | $1.12B | 0.56% |
XPH | 38.62% | $158.65M | 0.35% |
SPHB | 38.45% | $268.07M | 0.25% |
QQQJ | 37.91% | $603.97M | 0.15% |
IWO | 37.43% | $11.19B | 0.24% |
VBK | 37.07% | $18.35B | 0.07% |
SECT | 37.00% | $1.88B | 0.78% |
XSD | 36.94% | $1.16B | 0.35% |